Funds advised by European mid-market private equity firm Triton have agreed to sell BlitzLuxCo, the holding company of pharmaceutical packaging producer Bormioli Pharma Group, to Gerresheimer, a systems and solutions provider for the pharma, biotech and cosmetics industries.
The transaction is expected to close in Q4 2024.
Triton acquired Bormioli in 2017 via a corporate carveout. In a press statement, the firm said that it had helped improve Bormioli’s management team, organisational and operational structure, as well as expand the company’s manufacturing base and oversee four acquisitions.
Andrea Lodetti, CEO of Bormioli Pharma Group, added that the company had been “able to build out our positions across pharma packaging, with one-stop-shop capabilities in terms of technology as well as product offering” during Triton’s ownership.
BNP Paribas and Goldman Sachs International acted as M&A financial advisors.
Source: Private Equity Wire
Can’t stop reading? Read more
Ares raises $7.1bn for credit secondaries in largest inaugural fundraise
Ares raises $7.1bn for credit secondaries in largest inaugural fundraise Ares Management has...
CVC-backed Global Sport Group launches €2.7bn debt raise to fund sports dealmaking
CVC-backed Global Sport Group launches €2.7bn debt raise to fund sports dealmaking Global Sport...
Warburg Pincus weighs €1.5bn defence fund as European rearmament accelerates
Warburg Pincus weighs €1.5bn defence fund as European rearmament accelerates Warburg Pincus is...